BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

487 related articles for article (PubMed ID: 23023712)

  • 21. Morphologic transformation of follicular lymphoma is associated with somatic mutation of the translocated Bcl-2 gene.
    Matolcsy A; Casali P; Warnke RA; Knowles DM
    Blood; 1996 Nov; 88(10):3937-44. PubMed ID: 8916960
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mantle cell lymphoma: 2013 Update on diagnosis, risk-stratification, and clinical management.
    Vose JM
    Am J Hematol; 2013 Dec; 88(12):1082-8. PubMed ID: 24273091
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Minimal residual disease detection in mantle cell lymphoma: methods and significance of four-color flow cytometry compared to consensus IGH-polymerase chain reaction at initial staging and for follow-up examinations.
    Böttcher S; Ritgen M; Buske S; Gesk S; Klapper W; Hoster E; Hiddemann W; Unterhalt M; Dreyling M; Siebert R; Kneba M; Pott C;
    Haematologica; 2008 Apr; 93(4):551-9. PubMed ID: 18379010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular insights into the immunopathogenesis of follicular lymphoma.
    Stamatopoulos K; Kosmas C; Belessi C; Stavroyianni N; Kyriazopoulos P; Papadaki T
    Immunol Today; 2000 Jun; 21(6):298-305. PubMed ID: 10825742
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rituximab induces effective clearance of minimal residual disease in molecular relapses of mantle cell lymphoma.
    Ladetto M; Magni M; Pagliano G; De Marco F; Drandi D; Ricca I; Astolfi M; Matteucci P; Guidetti A; Mantoan B; Bodoni CL; Zanni M; Boccadoro M; Gianni AM; Tarella C
    Biol Blood Marrow Transplant; 2006 Dec; 12(12):1270-6. PubMed ID: 17162208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Structure of Bcl-1 and IgH-CDR3 rearrangements as clonal markers in mantle cell lymphomas.
    Pott C; Tiemann M; Linke B; Ott MM; von Hofen M; Bolz I; Hiddemann W; Parwaresch R; Kneba M
    Leukemia; 1998 Oct; 12(10):1630-7. PubMed ID: 9766510
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A subset of t(11;14) lymphoma with mantle cell features displays mutated IgVH genes and includes patients with good prognosis, nonnodal disease.
    Orchard J; Garand R; Davis Z; Babbage G; Sahota S; Matutes E; Catovsky D; Thomas PW; Avet-Loiseau H; Oscier D
    Blood; 2003 Jun; 101(12):4975-81. PubMed ID: 12609845
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An uncommon case of de novo CD10+ CD5- mantle cell lymphoma mimics follicle center B cell lymphoma.
    Zapata M; Budnick SD; Bordoni R; Li S
    Int J Clin Exp Pathol; 2010 Mar; 3(4):430-6. PubMed ID: 20490333
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Indolent mantle cell lymphoma with nodal involvement and mutated immunoglobulin heavy chain genes.
    Nodit L; Bahler DW; Jacobs SA; Locker J; Swerdlow SH
    Hum Pathol; 2003 Oct; 34(10):1030-4. PubMed ID: 14608537
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Follicular lymphoma with a novel t(14;18) breakpoint involving the immunoglobulin heavy chain switch mu region indicates an origin from germinal center B cells.
    Fenton JA; Vaandrager JW; Aarts WM; Bende RJ; Heering K; van Dijk M; Morgan G; van Noesel CJ; Schuuring E; Kluin PM
    Blood; 2002 Jan; 99(2):716-8. PubMed ID: 11781262
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of 4 mantle cell lymphoma cell lines.
    Amin HM; McDonnell TJ; Medeiros LJ; Rassidakis GZ; Leventaki V; O'Connor SL; Keating MJ; Lai R
    Arch Pathol Lab Med; 2003 Apr; 127(4):424-31. PubMed ID: 12683869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Update on the molecular pathogenesis and targeted approaches of mantle cell lymphoma: summary of the 12th annual conference of the European Mantle Cell Lymphoma Network.
    Dreyling M; Amador V; Callanan M; Jerkeman M; Le Gouill S; Pott C; Rule S; Zaja F;
    Leuk Lymphoma; 2015 Apr; 56(4):866-76. PubMed ID: 25015778
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Blastoid variants of mantle cell lymphoma: frequent bcl-1 rearrangements at the major translocation cluster region and tetraploid chromosome clones.
    Ott G; Kalla J; Ott MM; Schryen B; Katzenberger T; Müller JG; Müller-Hermelink HK
    Blood; 1997 Feb; 89(4):1421-9. PubMed ID: 9028966
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mantle cell lymphoma with 8q24 chromosomal abnormalities: a report of 5 cases with blastoid features.
    Hao S; Sanger W; Onciu M; Lai R; Schlette EJ; Medeiros LJ
    Mod Pathol; 2002 Dec; 15(12):1266-72. PubMed ID: 12481006
    [TBL] [Abstract][Full Text] [Related]  

  • 35. One translocation for 2 lymphoid neoplasms.
    Aussedat G; Baseggio L
    Blood; 2019 Jan; 133(2):180. PubMed ID: 30630847
    [No Abstract]   [Full Text] [Related]  

  • 36. IgH partner breakpoint sequences provide evidence that AID initiates t(11;14) and t(8;14) chromosomal breaks in mantle cell and Burkitt lymphomas.
    Greisman HA; Lu Z; Tsai AG; Greiner TC; Yi HS; Lieber MR
    Blood; 2012 Oct; 120(14):2864-7. PubMed ID: 22915650
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transvection mediated by the translocated cyclin D1 locus in mantle cell lymphoma.
    Liu H; Huang J; Wang J; Jiang S; Bailey AS; Goldman DC; Welcker M; Bedell V; Slovak ML; Clurman B; Thayer M; Fleming WH; Epner E
    J Exp Med; 2008 Aug; 205(8):1843-58. PubMed ID: 18625744
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Common consensus LNA probe for quantitative PCR assays in cancer: vehicles for minimal residual disease detection in t(11;14) and t(14;18) positive malignant lymphomas.
    Sørensen CD; Jørgensen JM; Nederby L; Hokland P; Nyvold CG
    J Immunol Methods; 2014 Apr; 406():131-6. PubMed ID: 24631717
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atypical cytogenetic presentation of t(11;14) in mantle cell lymphoma.
    Gazzo S; Felman P; Berger F; Salles G; Magaud JP; Callet-Bauchu E
    Haematologica; 2005 Dec; 90(12):1708-9. PubMed ID: 16330452
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The t(11;14) (q13;q32) in multiple myeloma cell line KMS12 has its 11q13 breakpoint 330 kb centromeric from the cyclin D1 gene.
    Vaandrager JW; Kluin P; Schuuring E
    Blood; 1997 Jan; 89(1):349-50. PubMed ID: 8978314
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.